These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 6150491)

  • 41. [Clinical study of a new tranquilizer, Lexotan, in neurotic disorders].
    De Geyter J; Dumont E; Stenier P
    Sem Hop Ther; 1975 Apr; 51(4):247-52. PubMed ID: 5776
    [No Abstract]   [Full Text] [Related]  

  • 42. Controlled comparison of two anxiolytic benzodiazepines, cloxazolam and bromazepam.
    Ansseau M; von Frenckell R
    Neuropsychobiology; 1990-1991; 24(1):25-9. PubMed ID: 1983433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental comparison of low doses of 1.5 mg fluspirilene and bromazepam in out-patients with psychovegetative disturbances.
    Hassel P
    Pharmacopsychiatry; 1985 Sep; 18(5):297-302. PubMed ID: 2864709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Placebo-controlled study on acute and subchronic effects of buspirone vs bromazepam utilizing psychomotor and cognitive assessments in healthy volunteers.
    Schaffler K; Klausnitzer W
    Pharmacopsychiatry; 1989 Jan; 22(1):26-33. PubMed ID: 2565582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multi-centre, double-blind parallel trial of bromazepam ('Lexotan') and lorazepam to compare the acute benefit-risk ratio in the treatment of patients with anxiety.
    Cordingley GJ; Dean BC; Hallett C
    Curr Med Res Opin; 1985; 9(7):505-10. PubMed ID: 2863089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
    Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anxiety states and bromazepam (author's transl)].
    Ferreri M; Alby JM
    Nouv Presse Med; 1982 May; 11(22):1728-30. PubMed ID: 6124944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multicenter study on the effectiveness and tolerance of a bromazepam + propantheline combination in patients with irritable bowel syndrome].
    Dioguardi N; Agape D; Antoniozzi F; Ballarin E; De Franchis R; Ferrari A; Fesce E; Grimoldi D; Pozzi M; Psilogenis M
    Minerva Dietol Gastroenterol; 1987; 33(2):155-67. PubMed ID: 2888056
    [No Abstract]   [Full Text] [Related]  

  • 49. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term quazepam treatment of insomnia in geriatric patients.
    Caldwell JR
    Pharmatherapeutica; 1982; 3(4):278-82. PubMed ID: 6128741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Lorazepam (Temesta) versus bromazepam (Lexotanil). A controlled cross-study].
    Modestin J; Hodel J
    MMW Munch Med Wochenschr; 1976 Oct; 118(41):1335-6. PubMed ID: 11410
    [No Abstract]   [Full Text] [Related]  

  • 53. Stress protective effects during steady-state conditions of bromazepam.
    Ziegler G; Ludwig L; Klotz U
    Pharmacopsychiatry; 1984 Nov; 17(6):194-8. PubMed ID: 6151200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Open study of bromapezan in ambulatory and psychiatric hospital patients (author's transl)].
    Singer L; Danion JM; Roos M; Levy A; Wetta JM; Singer P; Lehr D; Ferretto JL; Keppi J; Bouhey J
    Nouv Presse Med; 1982 May; 11(22):1725-7. PubMed ID: 6124943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bromazepam and lorazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Mercier P; Beaudry P; Annable L; Chouinard G
    Acta Psychiatr Scand; 1986 Nov; 74(5):451-8. PubMed ID: 2880459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A double-blind comparison of the anxiolytic activity of two benzodiazepines, metaclazepam and bromazepam, in anxiety neurosis.
    Bilone F; Roncari R
    Curr Med Res Opin; 1988; 11(1):45-7. PubMed ID: 2898321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK; Mallinckrodt CH; Detke MJ; Watkin JG; Tollefson GD
    J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of Cavain in patients suffering from anxiety.
    Lehmann E; Klieser E; Klimke A; Krach H; Spatz R
    Pharmacopsychiatry; 1989 Nov; 22(6):258-62. PubMed ID: 2575765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.